EICHOR
● Active Not Recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Colitis, Ulcerative · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in participants with moderately to severely active ulcerative colitis (UC).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (236)
| Research Solutions of Arizona | Litchfield Park, Arizona, United States | — |
| Om Research LLC 1 | Apple Valley, California, United States | — |
| Om Research LLC | Lancaster, California, United States | — |
| Medical Associates Research Group, Inc. | San Diego, California, United States | — |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | — |
| Gastro Florida | Clearwater, Florida, United States | — |
| I.H.S. Health. LLC | Kissimmee, Florida, United States | — |
| Columbus Clinical Services LLC | Miami, Florida, United States | — |
| Vista Health Research, LLC | Miami, Florida, United States | — |
| Orlando Health | Orlando, Florida, United States | — |
| Theia Clincial Research, LLC | Temple Terrace, Florida, United States | — |
| Digestive Healthcare of Georgia, P.C | Atlanta, Georgia, United States | — |
+ 224 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05528510